Cross-section (Cross Section)
Backing Membrane*
Scopolamine Trandermal System Patch, Extended Release
Product Images NDC 72162-1419
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine Trandermal System (NDC 72162-1419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Figure 1)
Not available.*
Figure-2 (Figure 2)
Figure-3 (Figure 3)
Figure-4 (Figure 4)
Figure-5 (Figure 5)
This text seems to describe a transdermal system that is tan-colored. The text does not provide any further details about the system.*
Label (Lbl721621419)
The text describes a transdermal system that contains scopolamine, which is formulated to deliver approximately 1 mg of the medication over a period of 3 days. The system should be kept out of reach of children and stored at a temperature between 20°C to 25°C (68°F to 77°F). It may cause drowsiness and blurred vision, so caution should be exercised when using it. The system is foil-sealed for protection, and it should not be used if the seal is broken. The transdermal system should be used one at a time and should not be cut.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
